As a mage, I just want to pursue the truth

Chapter 82 On the Day of Launch
Daily financial advice:

"Science and Technology Innovation Board finally welcomes the leader"

"On October 2021, 10, Sinovation Biotechnology (*****.SH) was listed on the Science and Technology Innovation Board of the Shanghai Stock Exchange. As of now, Sinovation Biotechnology is priced at 8 yuan per share, an increase of 2295.09%. On the first day of listing, it soared by more than 125.4% during the call auction period. As the "first stock in brain-computer connection and innovative drugs", Sinovation Biotechnology set a record for the A-share market with the highest market value of new stocks listed this year.

Ke Chuang Bio has the highest issue price in the history of A-shares, and winning one lot requires more than 50 yuan.

As of now, users who have won the lottery for Kechuang Bio have earned more than 50 yuan per lottery ticket. This stock is also the new stock with the highest profit in the history of the A-share market.

Kechuang Bio is a biopharmaceutical research and development company that provides patent licensing for brain-computer interface chips, α-endorphin manufacturing and patent licensing.

Since its establishment, the company has continuously achieved breakthrough technological innovations in the fields of innovative drugs and brain-computer connections. It also owns a full set of patents for brain-computer connection chips and patents for industrial large-scale production of endorphins, and has the ability to produce endorphins on a large scale.

The market believes that the company's high issue price and the fact that its stock price can still perform so well in the context of the overall sluggish biopharmaceutical market are inseparable from its moat.

The strategy team of Guotai Junan Securities said that from a strategic perspective, the current pharmaceutical market has reached a stage of differentiation: with the industry trend continuing and the growth space still to be realized, the biopharmaceutical industry will continue to be optimistic in the medium and long term, but it is necessary to choose biopharmaceutical companies with moats and innovation capabilities. Biopharmaceutical companies such as Kechuang Biotech still have investment opportunities. "

The leader of the main board is Moutai, and the leader of the ChiNext is CATL. Previously, investors hoped that SMIC could become the leader of the Science and Technology Innovation Board.

However, it is difficult for SMIC, which has been falling all the way, to meet expectations. Its market value of less than 400 billion yuan cannot compare with CATL and Moutai.

"Science and Technology Innovation Biotechnology is the leader of the Metaverse. In the short term, it is expected to reach 3000 yuan, in the medium term, 5000 yuan, and in the long term, 10000 yuan!"

In the comments below the daily financial advice, this kind of person is drinking too much and randomly pressing zero on a calculator.

“Why didn’t I win the lottery (tears) (tears)? I was just one digit away from winning the lottery, and five hundred thousand just passed me by (tears)”

"Zheng Li is really amazing. Three years after starting his business, the valuation of his company is approaching 1 trillion yuan."

"I don't think the price is high at all. I bought one and kept it for my son."

"There are still many positive news for Kechuang Biotechnology that have not yet been revealed, such as when the brain-computer connection technology will be sold to Europe and the United States, the progress of new drug research and development, the application of brain-computer connection technology in other fields, and the combination of brain-computer connection technology with VR. There are too many possible profit points."

"8000 billion is just the current valuation of Sinovation Biotechnology. If we consider the future growth potential, no A-share company can compare to Sinovation Biotechnology."

"Science Bio has a moat comparable to that of Pien Tze Huang, stronger growth potential than SMIC, and a better net profit margin than Aimei. This valuation is completely underestimated!"

“When will A-shares label Kechuang Biotechnology as a metaverse company? It is not only a pharmaceutical and semiconductor company, it is also the purest metaverse concept stock!”

“Will the suspension be triggered today?”

After new stocks on the Science and Technology Innovation Board are listed, if the price differs from the opening price by more than 30%, they will be suspended during trading.

"The price is too high. One lot costs more than 200,000 yuan. Small investors can forget about participating. It is completely in the hands of institutions."

"Such a large market has seen such a crazy rise on the first day. It must be due to large-scale purchases by institutions. If it were retail investors, they would not be able to lift the sedan chair. I am still very optimistic about the future development of Sinopharm Biotech."

Whether it is the price, the hot market, or the legendary nature of Ke Chuang Bio itself, investors are extremely enthusiastic about discussing it.

The stock bar of Ke Chuang Bio was directly pushed to the top of the popularity ranking list.

The final closing price of Kechuang Bio was fixed at 2408.01 yuan, making it the company with the highest unit price in the A-share market at present, and one of only two companies in the A-share market with a share price of more than yuan, the other one being Moutai.

At the celebration banquet held by the Science and Technology Biology Organization in the evening, the noisy atmosphere almost broke through the ceiling.

Li Miaomiao didn't drink much, she was a little unaccustomed to the excessive courtesy of the people around her. Her colleagues also knew her relationship with Zheng Li, and no one dared to show any improper thoughts towards her.

Afterwards, Li Miaomiao asked the driver to take her and Li Shuyao home.

Although Li Shuyao was an intern on this project, she was also invited to attend the celebration banquet because she was Li Miaomiao's sister.

Whether it was Li Shuyao's family background, her identity as Li Miaomiao's sister, or her education and appearance, they all became the targets pursued by men at the celebration party.

Many men in the financial industry are still unmarried in their thirties, and Li Shuyao is almost a perfect marriage partner for them.

After getting in the back seat of the car, Li Shuyao sat up straight abruptly. "It feels great to get rich overnight, right?"

Li Miaomiao was startled: "You're not drunk?"

Li Shuyao smiled innocently: "How much red wine did you drink? You are still far from being drunk~"

"I'll rely on you from now on. What percentage of Zheng Li's shares does a company with a market value approaching one trillion yuan have?"

Li Miaomiao: "About sixty-three."

Li Shuyao shook her head: "It's really exaggerated. He's only in his early twenties and his net worth is already as high as 500 billion RMB."

“Zuckerberg is no different.”

"You're lucky to have met Zheng Li, which is like winning 100 lottery tickets worth 5 million yuan in a row. I'm so lucky. I've also benefited from it."

"This afternoon, someone from CICC told me that I can join their investment banking department after graduation."

Li Miaomiao was happy for her sister. She clapped her hands and said, "Congratulations on getting what you wanted!"

“CICC is a good platform.”

Li Shuyao sighed and said, "If it were me in the past, I would definitely be very happy and would call my friends to celebrate."

"But now that I see my sister, who grew up with me, become a billionaire in one day, I feel like my efforts are useless."

"We grew up together and have a very good relationship. We rarely have arguments, but I still feel jealous and wonder why it's not me."

"I know this shouldn't happen, but it's normal and human nature."

"After what I've seen, if I want to go back to a normal 9-to-5 life, I feel like I need some time to cultivate myself."

Li Miaomiao smiled and said, "I never thought of this before. When Zheng Li and I went to Suzhou to start a business, our best guess was that we could successfully market endorphins."

"It can keep the company alive and operating normally."

"I never thought that Kechuang Bio could reach this point today."

Thanks to book friends 20201222095310546 and Zhixingheer for their rewards!

Women's football team beat Japan, men's football team lost to Vietnam.
Don't say that the women's football team is not as good as the men's football team in terms of competitive level. Just look at the spirit and energy they show. Do the men's football team have it? Alas~


(End of this chapter)